Sage Journals: Discover world-class research

Abstract

Objective

Conventional immunoassays detect autoantibodies related to systemic lupus erythematosus (SLE) via recognition of epitopes on autoantigens expressed in their denatured rather than native conformational state, casting difficulty in evaluating the genuine pathogenicity of the autoantibodies. We aimed to use a novel high-throughput protein microarray platform to identify autoantibodies against native autoantigens in SLE sera.

Methods

Sera from SLE patients and those of gender-, age-, and ethnicity-matched healthy controls (HC) were screened against more than 1,600 immune-related antigens of native conformation. The relative fluorescent unit readout from post-assay imaging were subjected to bioinformatics pre-processing and composite normalization. A penetrance fold change (pFC) analysis between SLE and HC samples shortlisted 50 autoantigens that were subjected to an unsupervised cluster analysis. Correlations between the pFC of putative autoantigens and clinical parameters including SLE disease activity index (SLEDAI-2K) and recent SLE flares were explored.

Results

381 autoantigens were identified when 15 SLE and 15 HC serum samples were compared. The top 20 autoantigens which elicited autoantibody responses in SLE sera filtered based on the highest pFC were further analyzed. Autoantigens which the putative autoantibodies reacted against are those involved in chromatin organization such as DEK, regulation of transcription activity including REOX4 and ELF4, and negative regulation of NF_kB activity such as TRIB3. Additionally, the pFC of these autoantibodies significantly and positively correlated with SLEDAI-2K and recent SLE flares.

Conclusion

A high-throughput protein microarray platform allows detection and quantification of putative lupus-related autoantibodies which are of potential pathophysiological and prognostic significance in SLE patients.

Keywords

Autoantibody lupus high-throughput microarrays proteins

Get full access to this article

View all access options for this article.

References

Kwon

Chun

Kim

Mak

Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond. Cells 2019; 8: 1180.

Tan

MKX

Heng

TYJ

Mak

The potential use of metformin, dipyridamole, N-acetylcysteine and statins as adjunctive therapy for systemic lupus erythematosus. Cells 2019; 8: 323.

Sun

Guo

Sun

, et al. Development and validation of an ELISA using a protein encoded by ORF2 antigenic domain of porcine circovirus type 2. Virol J 2010; 7: 274.

Van Regenmortel

MH.

Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines.

J Mol Recognit 2006; 19: 183–187.

Chen

Hsieh

, et al. Development of a highly sensitive enzyme-linked immunosorbent assay (ELISA) through use of poly-protein G-expressing cell-based microplates. Sci Rep 2018; 8: 17868.

Garcia

Castillo

Gonzales

, et al. Low sensitivity and frequent cross-reactions in commercially available antibody detection ELISA assays for Taenia solium cysticercosis. Trop Med Int Health 2018; 23: 101–105.4

Sengenics UK Ltd. Sengenics KREX presentation, www.sengenics.com/wp-content/uploads/2018/04/US8999897.pdf

Hochberg

MC.

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Arthritis Rheum 1997; 40: 1725.

Petri

Orbai

Alarcón

, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–2686.

10.

Parodis

Emamikia

Gomez

Gunnarsson

van Vollenhoven

Chatzidionysiou

Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies. Expert Opin Biol Ther 2019; 19: 157–168.

11.

Stoll

Seifert

Isenberg

DA.

SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus.

Br J Rheumatol 1996; 35: 248–254.

12.

Lewis

Mcandrew

Wheeler

, et al. Autoantibodies targeting TLR and SMAD pathways de fi ne new subgroups in systemic lupus erythematosus. J Autoimmun 2018; 91: 1–12.

13.

Vogt

Nagel

Cluster analysis in diagnosis.

Clin Chem 1992; 38: 182–198.

14.

Gourzi

Kapsogeorgou

Kyriakidis

Tzioufas

AG.

Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren’s syndrome.

Clin Exp Immunol 2015; 182: 14–22.

15.

Dong

Wang

Kabir

, et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum 2000; 43: 85–93.

16.

Mor-Vaknin

Rivas

Legendre

, et al. High levels of DEK autoantibodies in sera of patients with polyarticular juvenile idiopathic arthritis and with early disease flares following cessation of anti-tumor necrosis factor therapy. Arthritis Rheumatol 2018; 70: 594–605.

17.

Schnittger

De Veylder

The dual face of cyclin B1.

Trends Plant Sci 2018; 23: 475–478.

18.

Lee

Daniels

Garnett

Venkitaraman

AR.

A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor. Oncogene 2011; 30: 3360–3369.

19.

Paull

Haykinson

Johnson

RC.

The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures.

Genes Dev 1993; 7: 1521–1534.

20.

Walavalkar

Gordon

Williams

Jr.

Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (MBD2) homologues and GATA zinc finger domain containing 2A (GATAD2A/p66α). J Biol Chem 2013; 288: 3419–3427.

21.

Yamada

Park

Mamonkin

Lacorazza

HD.

Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2.

Nat Immunol 2009; 10: 618–626.

22.

Krishnamurthy

Ngam

Berdis

Montano

MM.

The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites.

Oncogene 2011; 30: 4731–4739.

23.

Hong

Jiang

Dai S, Xu T, Li H and Yasui A. The role of hnRPUL1 involved in DNA damage response is related to PARP1. PLoS One 2013; 8: e60208.

24.

Casadevall

Pirofski

LA.

A new synthesis for antibody-mediated immunity.

Nat Immunol 2011; 13: 21–28.

25.

Fritzler

MJ.

Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent.

Auto Immun Highlights 2012; 3: 51–58.

26.

Yaniv

Twig

Shor

, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev 2015; 14: 75–79.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB

0.09 MB

0.02 MB